IDO2 and myelodysplastic syndrome: Moreover, tryptophane catabolism into kynurenine via the enzyme indoleamine 2,3-dioxygenase may be a novel target to inhibit MDS progression, as in MDS, dysregulation of tryptophan break down may inhibit hematopoietic stem cell expansion, contributing to blood cytopenia [57,58].